Last reviewed · How we verify
NCT04660968: DATE
Dyadic Approach To Active Living and Eating Healthy: The DATE Study
NA trial testing Dyadic health behaviour change intervention in Obesity in 70 participants. Status unknown.
15 June 2023
Quick facts
| Lead sponsor | Concordia University, Montreal |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 15 December 2020 |
| Primary completion | 15 June 2023 |
| Estimated completion | 15 November 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Dyadic health behaviour change intervention
- Dyadic nutrition counselling intervention
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Concordia University, Montreal
Who can join
Adults 50 to 75, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the DATE study is to evaluate the feasibility and acceptability and a preliminary evaluation of the efficacy of a dyadic health behaviour change intervention to improve healthy eating, physical activity, and dyadic coping among older obese couples. This novel intervention will use a dyadic adaptation of common health behaviour change strategies and will promote a dyadic coping approach to health behaviour change that emphasize partners' interdependence and shared responsibility for the creation of a home environment conducive to a healthy lifestyle. For this project 35 obese older adults cohabiting dyads will be randomized to either the couples-based dyadic health behaviour change intervention or a couples-based nutrition counselling control condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04660968
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Concordia University, Montreal trials
Trials by the same sponsor.
- NCT06487234 — Effect of Acute ObeEnd Exposure on Factors Regulating Appetite · NA · recruiting
- NCT06186297 — Boosting Performance: The Power of Cranberry Supplementation · NA · completed
- NCT07011784 — Dance and Blood Flow Restriction as Balance Training for Older Women · NA · active not recruiting
- NCT05823857 — Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain · NA · completed
- NCT06411483 — Determining the Physiological Mechanisms Behind the ObeEnd Device on Factors Regulating Appetite · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04660968 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Concordia University, Montreal
- Last refreshed: 22 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660968.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing